ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) has been researched along with Thalassemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhargava, KK; Cerami, A; Grady, RW; Peterson, CM | 1 |
| Brown, EB | 1 |
2 review(s) available for ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) and Thalassemias
| Article | Year |
|---|---|
Clinical management of thalassemia. The status of new iron chelators.
Topics: Animals; Chelating Agents; Chemical Phenomena; Chemistry; Cholic Acids; Deferoxamine; Drug Evaluation; Drug Evaluation, Preclinical; Enterobactin; Ethylenediamines; Humans; Hydroxamic Acids; Hydroxybenzoates; Iron; Pentetic Acid; Piperazines; Thalassemia | 1980 |
Recognition and treatment of iron overload.
Topics: Adult; Blood Grouping and Crossmatching; Bloodletting; Costs and Cost Analysis; Deferoxamine; Ethylenediamines; Female; Ferritins; Hemochromatosis; Humans; Iron; Iron Chelating Agents; Liver; Male; Thalassemia; Transferrin; Transfusion Reaction | 1980 |